🔴 Park Ha Biological Technology is trading 6.25% down today despite broader biotech gains

Park Ha Biological Technology is trading at $2.70, down 6.25%, while the immediate catalyst remains unclear.

• The stock extended its decline from $2.88 on August 24, 2026, and $3.00 on August 21, 2026.
• No clear company-specific announcement dated August 25, 2026 was identified; recent coverage focuses on investor-law-firm notices regarding an existing securities lawsuit, while CNBC reports no recent news for the security.
• The broader biotech sector is higher, so sector strength does not explain the weakness.